We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EAH Eco Animal Health Group Plc

0.50 (0.54%)
01 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.54% 93.00 146,665 10:04:23
Bid Price Offer Price High Price Low Price Open Price
92.00 94.00 93.00 92.50 92.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chem,fertlizer Minrl Mng,nec 85.31M 1.01M 0.0149 62.42 63M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:26:49 O 820 92.24 GBX

Eco Animal Health (EAH) Latest News

Eco Animal Health (EAH) Discussions and Chat

Eco Animal Health Forums and Chat

Date Time Title Posts
19/2/202418:44Eco Animal Health Group: Early dewormer gets OK1,528

Add a New Thread

Eco Animal Health (EAH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Eco Animal Health (EAH) Top Chat Posts

Top Posts
Posted at 03/3/2024 08:20 by Eco Animal Health Daily Update
Eco Animal Health Group Plc is listed in the Chem,fertlizer Minrl Mng,nec sector of the London Stock Exchange with ticker EAH. The last closing price for Eco Animal Health was 92.50p.
Eco Animal Health currently has 67,744,889 shares in issue. The market capitalisation of Eco Animal Health is £63,002,747.
Eco Animal Health has a price to earnings ratio (PE ratio) of 62.42.
This morning EAH shares opened at 92.50p
Posted at 17/2/2024 17:26 by cerrito
I see the price has drifted down in the last few days with both Wednesday and Friday busy by EAH standards.
I note last year we had a TU on March 8th and the year before on March 15th and am going on the basis that we will have one in the first half of this March.
Posted at 08/2/2024 11:11 by mr macgregor
China pork price slumped 17% in January.
Posted at 13/1/2024 18:29 by cerrito
Saw this on Citywire this week.
Vet pharmaceutical group Eco Animal Health (EAH) had a challenging 2023 and there is ‘significant value on offer’, says Shore Capital.

Analyst Sean Conroy reiterated his ‘buy recommendation on the stock, which was trading at 109p on Monday.

It had a difficult 2023 due to its primary customer base, pork producers, dealing with depressed hog prices and elevated feed costs.

‘Despite this Eco Animal Health has delivered decent growth and continued to gain share with (pig disease treatment) Aivlosin, an impressive feat in our view, and certainly one that helps speak to its commercial prowess,’ said Conroy.

This year, Conroy said that there is ‘ample scope for Eco Animal Health to sustain sales momentum and, given the strength of the performance in the first half, potentially beat our full-year 2024 forecasts’.

‘The latest set of interim results have helped to reaffirm our conviction that there is still significant value on offer from Eco Animal Health’s core, commercial business, and additional upside to be realised from its R&D pipeline.’
Posted at 08/1/2024 07:35 by ariane
8 January 2024

ECO Animal Health Group plc

("ECO" or the "Company")

Disposal of Freehold Properties

ECO Animal Health Group plc (AIM: EAH) announces that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey. This was the former registered office of the Company and following relocation of all functions to its office in Southgate, London, the office was surplus and unused. The net consideration received for the sale of this property was GBP831,454. The carrying value of the property was GBP565,000.

Additionally, on 28 November 2023, the Company's freehold property at Western Road, Mitcham was sold to its long term occupier (an education charity) for net consideration of GBP227,000. This matched its carrying value and the previous rent payable was a peppercorn.

The total cash received from these two property sales was GBP1,058,454 after fees and expenses.

The Board intends to use the majority of the net proceeds to advance the growth aspirations of ECO. In due course, the Board also intends to use some of the proceeds to purchase ordinary shares of the Company in the market to cover possible future vesting of employee share-based incentives including share options, long term incentive plans and the deferred bonus scheme. In order to carry out such market purchases, the Company will need to seek approval from shareholders in a general meeting.
Posted at 05/12/2023 10:21 by mr macgregor
You can see why EAH are deflecting from China.
Posted at 28/11/2023 20:31 by cerrito
Having a look at the interims before the call tomorrow. You are right Mr Macgregor to point out that they are delphic in their silence on China. Good to read about good cash balances ex China. 
Good for them for spelling out so clearly where the cash is located and go bing us their understanding of current market consensus.I note that full year revenue forecast of £88m suggests H2 revenue of £50m broadly on a par with H2 22/23.The full year adjusted Ebitda of £7.7m suggests a H2 figure of £7m, compared to £5.6m in H2 22/23.Good if they can do it.I am not a great fan of ebitda, especially if adjusted. I see here that the I is negligible, but I see the d&a was £2.3m in the last FY and £1.2m in H1 of the current FY. The issue is tax, with a 93pc effective tax rate in H1, albeit 32pc in the last financial year.I note that Singers have reconfirmed the target price of 268p. If their R&D efforts pay off perfectly possible  they get to this figure but we may well have to wait till calendar  2026 at the very earliest. The 2.5p  Share price increase this week seems fair enough and as long as none of the major shareholders lose patience, we should avoid going into double figure territory. On that note since February we have only has 2 TR-1 notices and on both cases it was for an increase in holding(L Odier and Schroders). Incidentally they talk about API and I had no idea what they were talking about till I read in my notes it is the secret sauce for Aivlosin. 
Posted at 10/11/2023 07:30 by aimspec
Looks like they are dressing the company up for sale. Showing pipeline rev/EBITDA/GM bridge for most products. Clearly frustrated about no NPV assigned from pipeline on share price. On that bridge, company EBITDA 2025 looks materially higher than 2024 which I didn’t understand given limited effect from pipeline products at that stage.
Posted at 07/11/2023 20:47 by cerrito
Yes,PUGUGLY,I saw that and here is the link

They mention a company called Muyuan whose shares are down 20pc this year and had to pull a listing on the Zurich stock exchange.
I have to say EAH has been out of sight out of mind for me.
I agree that at macro level is not good news for EAH, although the article does reiterate what we have learnt before that small producers are being squeezed out in favour of larger ones which should help EAH in the long term.
I have registered for the Thursday presentation.
I wondered if we were going to get the interims on Thursday but probably they will come out in 2/3 weeks time nd they are often flagged in advance.
Posted at 13/7/2023 15:51 by cerrito
A good and professional presentation in the ED webinar and questions well answered.I would recommend people to watch it.
I note strong H2 and strong start for the current FY, their point on geographic diversity and their promising new product pipeline and the fact that they have sidestepped the UK regulatory authorities and are dealing with the USDA, who they say are efficient and speedy. Also good to get steer that reasonable to think that we can get £4m of dividends this FY from the wholly owned sub in China.
That said while I have no intention of selling I am reluctant to buy more.
By my standards I have more than enough invested here. I had a rush of blood to the head 5 years ago to the month and made my first purchase at 540. My current inprice is 170.
I do not feel comfortable that I understand the industry well enough and the competitive landscape. In their note ED do address these issues.
There is the China situation. If anything were to happen with Taiwan all bets are off, especially as all their secret sauce is manufactured there. Perhaps naively I do not see them as having issues domestically with the Chinse government as what EAH does is in line with the interests of the CCP namely keep pork/poultry prices down.
The main issue is that at least from the current product lines, I cannot see where growth is coming from,and as Topvest says the PE is very generous. Indeed as per Singers even in FY26 it will be 51x.

I am having difficulty in sharing the excitement of EAH in their new products and R&D programme. Trying to work out why I have this blind spot. One reason is that a company looking to bring a new medicine in the human health field will tell us information on how many people in a given country suffer from the disease and some idea of the monetary figures involved. There will often be a comment on what their new proposed drug/vaccine brings to the party compared to existing products. I have not found this with the EAH pipeline. It may well be that I have looked in the wrong place and/or it will be in the Annual Report or Capital Markets Day.
Posted at 09/1/2023 09:10 by cerrito
Given the ANP news this morning especially with reference to China was expecting a slight fall here but of course the current EAH share price has alot of bad-even if transitory - news baked in.
Eco Animal Health share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |